Simon Jeremy Fry
CIK: 0002046305
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CONDUIT PHARMACEUTICALS INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 12, 2025CDT
CDT Equity Inc.
Award(A)Direct35K shares- - Aug 5, 2025CDT
CDT Equity Inc.
Award(A)DirectStock Option (Right to Buy)
15K shares- - Mar 30, 2025CDT
CONDUIT PHARMACEUTICALS INC.
Award(A)Direct29.4K shares at avg. $0.89$26K - Dec 18, 2024CDT
CONDUIT PHARMACEUTICALS INC.
Award(A)DirectStock Option (Right to Buy)
420K shares at avg. $0.07-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2025 | CDT CDT Equity Inc. | Award(A) | 35,000 | - | - | Direct |
| Aug 5, 2025 | CDT CDT Equity Inc. | Award(A) Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| Mar 30, 2025 | CDT CONDUIT PHARMACEUTICALS INC. | Award(A) | 29,354 | $0.89 | $26,125 | Direct |
| Dec 18, 2024 | CDT CONDUIT PHARMACEUTICALS INC. | Award(A) Stock Option (Right to Buy) | 420,000 | $0.07 | - | Direct |
1-4 of 4 transactions
About Fry Simon Jeremy
Fry Simon Jeremy (SEC CIK 0002046305) files insider reports with the SEC as Director of CONDUIT PHARMACEUTICALS INC. (CDT).
Signal8 holds 4 ownership filings by Fry Simon Jeremy (1 Form 3, 3 Form 4), filed between Dec 20, 2024 and Aug 26, 2025. Those filings report 4 transactions, from Dec 18, 2024 to Aug 12, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Fry Simon Jeremy's filings is in NAPLES, FL.
Recent filings by Fry Simon Jeremy
Other insiders filing for CONDUIT PHARMACEUTICALS INC. (CDT)
- Regan Andrew, Chief Executive Officer
- Manoira Corp, 10% Owner
- Taylor Mark Andrew, 10% Owner
- Farley Chele Chiavacci, Director
- Bligh James, Interim CFO
- Lewis-Hall Freda C, Director